About C2 Therapeutics
C2 Therapeutics is a company based in Redwood City (United States) founded in 2007 was acquired by Pentax Medical in January 2017.. C2 Therapeutics has raised $28.96 million across 9 funding rounds from investors including Pentax Medical and Main Line Equity Partners. The company has 16 employees as of December 31, 2021. C2 Therapeutics operates in a competitive market with competitors including EndoChoice, EndoGastric Solutions, CoapTech, SafeStitch and Endo Tools Therapeutics, among others.
- Headquarter Redwood City, United States
- Employees 16 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.96 M (USD)
in 9 rounds
-
Latest Funding Round
$6.3 M (USD), Series B
Dec 06, 2016
-
Investors
Pentax Medical
& 1 more
-
Employee Count
16
as on Dec 31, 2021
-
Acquired by
Pentax Medical
(Jan 09, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of C2 Therapeutics
C2 Therapeutics has successfully raised a total of $28.96M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $6.3 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $6.3M
-
First Round
First Round
(01 May 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Series B - C2 Therapeutics | Valuation |
investors |
|
| Oct, 2014 | Amount | Series B - C2 Therapeutics | Valuation |
investors |
|
| Sep, 2014 | Amount | Series B - C2 Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in C2 Therapeutics
C2 Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Pentax Medical and Main Line Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Main Line Equity Partners is engaged in private equity investments.
|
Founded Year | Domain | Location | |
|
Endoscopic imaging devices and solutions are developed and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by C2 Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - C2 Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
C2 Therapeutics Comparisons
Competitors of C2 Therapeutics
C2 Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EndoChoice, EndoGastric Solutions, CoapTech, SafeStitch and Endo Tools Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Devices, systems, and services are provided for GI specialists.
|
|
| domain | founded_year | HQ Location |
Incisionless transoral procedures for upper GI diseases are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive gastrostomy feeding tube placement method is developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for gastrointestinal and bariatric surgery are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheters for precision in gastroenterology are developed.
|
|
| domain | founded_year | HQ Location |
Implant to treat GERD
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about C2 Therapeutics
When was C2 Therapeutics founded?
C2 Therapeutics was founded in 2007.
Where is C2 Therapeutics located?
C2 Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is C2 Therapeutics a funded company?
C2 Therapeutics is a funded company, having raised a total of $28.96M across 9 funding rounds to date. The company's 1st funding round was a Series B of $2.55M, raised on May 01, 2007.
How many employees does C2 Therapeutics have?
As of Dec 31, 2021, the latest employee count at C2 Therapeutics is 16.
What does C2 Therapeutics do?
C2 Therapeutics develops ablation therapies to treat diseases of the gastrointestinal tract. The company has developed a cryoballoon focal ablation system for endoplasmic ablation of barretts tissue. As of October 2015, company has received CE mark and coldplay cryoballoon ablation system is available for sale in western Europe. Company has also received USFDA 510k approval for both coldplay cryoballoon full ablation system and coldplay cryoballoon swipe ablation system.
Who are the top competitors of C2 Therapeutics?
C2 Therapeutics's top competitors include CoapTech, Endo Tools Therapeutics and EndoChoice.
Who are C2 Therapeutics's investors?
C2 Therapeutics has 2 investors. Key investors include Pentax Medical, and Main Line Equity Partners.